NHS Grampian
84
13
14
44
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.0%
5 terminated/withdrawn out of 84 trials
89.8%
+3.2% vs industry average
5%
4 trials in Phase 3/4
9%
4 of 44 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (84)
The Use of Bispectral Index Monitoring to Assess Depth of Sedation in Patients With Traumatic Brain Injury
Role: collaborator
The ACDC Study Assessing Cognitive Deterioration in COVID-19
Role: lead
Radiomics in Rectal Cancer
Role: lead
A Cohort Study of Bioabsorbable Screws for Syndesmosis Fixation Fixation in Ankle Fracture
Role: lead
Using Patient Feedback in Mental Health Services
Role: lead
Photographic Rhinometry Following Derm/Mohs Surgery for Skin Cancers
Role: lead
Melatonin in Pregnancy
Role: collaborator
Chemotherapy Induced Cognitive Impairment
Role: collaborator
Melatonin in Pregnancy Compared to Non-pregnant
Role: collaborator
Estimating Premorbid Intellectual Functioning in Children and Measuring Change in Cognitive Functioning as Children Develop
Role: collaborator
Health Seeking Behaviour in Women Diagnosed With Gynaecological Cancer: Can it be Modified to Improve Patient Outcomes?
Role: lead
Scottish Advanced Fetal Research Study
Role: collaborator
PUFFINS Brain Health Study
Role: collaborator
Neural Correlates of Autistic Individuals With Anorexia Nervosa
Role: collaborator
Point of Care Evaluation of High-sensitivity Cardiac Troponin
Role: collaborator
Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity
Role: collaborator
Rebalancing the Fat Content of the Heart and Muscles
Role: collaborator
FCI-Glioblastoma Study
Role: collaborator
Understanding the Benefits of Dietary Fibre Supplementation in Patients With Prostate Cancer
Role: collaborator
Impact of External Factors(Brexit and Covid-19) on Retention and Turnover in the NHS
Role: lead